Simon M. Poucher - Concepedia

Author

Simon M. Poucher

Also Known As

S M Poucher, S. M. Poucher, S.M Poucher, S.M. Poucher, S. M. Poucher, SM Poucher, Simon M Poucher, Simon M. Poucher, Simon Poucher

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)University of Nottingham Queen's Medical Centre Bristol-Myers Squibb (United States)Nottingham Biomedical Research Centre

About

Simon M. Poucher is an author at AstraZeneca (United Kingdom) specializing in medicine, metabolism, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	479
2	Health Sciences	10	10	341
3	Biochemistry	4	4	139
4	Applied Physiology	3	3	115
5	Natural Sciences	1	1	24

Simon M. Poucher

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A<sub>2a</sub>selective adenosine receptor antagonist Simon M. Poucher, J R Keddie, Parminder Singh, British Journal of Pharmacology	1995	362
125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor. T M Palmer, Simon M. Poucher, Kenneth A. Jacobson, Molecular Pharmacology	1995	89
Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats Victor P. Bilan, Eman Salah, Sheldon Bastacky, Journal of Endocrinology Renal PathologyRenal InflammationOxidative StressObesityMetabolic Syndrome	2011	84
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats Franka. MacDonald, Joanne E. Peel, H. B. Jones, Diabetes Obesity and Metabolism	2010	83
Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia. James A. Timmons, Simon M. Poucher, Dumitru Constantin‐Teodosiu, Journal of Clinical Investigation Muscle FunctionBlood FlowClinical PhysiologyMuscle InjurySkeletal Muscle	1996	78
In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist J R Keddie, Simon M. Poucher, G R Shaw, European Journal of Pharmacology Molecular PharmacologySignal TransductionBiochemistryFunctional SelectivityMedicine	1996	69
Metabolic responses from rest to steady state determine contractile function in ischemic skeletal muscle James A. Timmons, Simon M. Poucher, Dumitru Constantin‐Teodosiu, American Journal of Physiology-Endocrinology and Metabolism	1997	68
The role of adenosine in exercise hyperaemia of the gracilis muscle in anaesthetized cats. Simon M. Poucher, C G Nowell, M G Collis The Journal of Physiology	1990	53
Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β‐cell mass in a streptozotocin‐induced mouse model of type 2 diabetes Simon M. Poucher, Sharon C. Cheetham, J. Francis, Diabetes Obesity and Metabolism	2012	50
Pharmacodynamics of ZM 241385, a Potent A2a Adenosine Receptor Antagonist, after Enteric Administration in Rat, Cat and Dog Simon M. Poucher, J R Keddie, Robert R. Brooks, Journal of Pharmacy and Pharmacology	1996	47

Page 1